SMO and metabolic dysfunction-associated steatotic liver disease: Thus, disrupting hepatocyte Smo activity revealed a unifying hepatocyte-driven mechanism that may explain the paradoxical observation that steatosis and insulin resistance typically correlate in NAFLD patients.